Novonesis (Novozymes) A/S B
Novonesis (Novozymes) A/S B/ DK0060336014 /
NSIS/B
|
2024-04-26 4:59:39 PM
|
Chg.
+4.90
|
Volume |
Bid5:10:00 PM |
Ask5:10:00 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
389.60DKK
|
+1.27%
|
460,091
Turnover: 178.44 mill. |
390.10Bid Size: 55 |
390.40Ask Size: 124 |
108.59 bill.DKK |
1.54% |
29.32 |
Fundamentals
| |
FY 2022 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
13.29 DKK |
17.40% |
| EPS Diluted: |
- DKK |
17.45% |
| Revenues per Share: |
62.97 DKK |
-3.86% |
| Book Value per Share: |
49.64 DKK |
-4.19% |
| Cash Flow per Share: |
14.37 DKK |
-19.24% |
| Dividend per Share: |
6.00 DKK |
9.09% |
| Total |
in mill. |
|
| Revenues: |
17,553.00 DKK |
17.40% |
| Net Income: |
3,686.00 DKK |
17.20% |
| Operating Cash Flow: |
4,006.00 DKK |
- |
| Cash and Cash Equivalents: |
1,041.00 DKK |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
29.32 |
26.48 |
| P/S Ratio: |
6.19 |
5.59 |
| P/BV ratio: |
7.85 |
7.09 |
| P/CF Ratio: |
27.11 |
24.48 |
| PEG: |
1.68 |
1.52 |
| Earnings Yield: |
3.41% |
3.78% |
| Dividend Yield: |
1.54% |
1.71% |
| Market Capitalization |
|
| Market Capitalization: |
108.59 bill. DKK |
98.09 bill. DKK |
| Free Float Market Cap.: |
- DKK |
- DKK |
| Market Cap. / Employee: |
16.01 mill. DKK |
14.46 mill. DKK |
| Shares Outstanding: |
278.73 mill. |
|
Profitability
| Gross Profit Margin: |
54.56% |
| EBIT Margin: |
25.98% |
| Net Profit Margin: |
21.00% |
| Return on Equity: |
26.64% |
| Return on Assets: |
13.17% |
Financial Strength
| Liquidity I / Cash Ratio: |
14.95% |
| Liquidity II / Quick Ratio: |
64.56% |
| Liquidity III / Current Ratio: |
132.72% |
| Debt / Equity Ratio: |
102.23% |
| Dynam. Debt / Equity Ratio: |
353.12% |
Efficiency
| Employees: |
6,781 |
| Personal Expenses / Employee: |
- DKK |
| Revenues / Employee: |
2,588,556.26 DKK |
| Net Income / Employee: |
543,577.64 DKK |
| Total Assets / Employee: |
4,126,677.48 DKK |
| * Fiscal Year End: |
2022-12-31 |
| Accounting Standard: |
IFRS |
